The groundbreaking approach of tirzepatide peptide represents a significant development in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects two pathways – GLP-1 and the GIP hormone – resulting in enhanced blood sugar management and anticipated weight loss. Experts are investigating its long-term advantages an